Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Aug 25;387(8):751-752.
doi: 10.1056/NEJMe2208454. Epub 2022 Jul 14.

Evidence for Step Therapy in Diabetic Macular Edema

David C Musch  1 , Emily Y Chew  1
Affiliations
Editorial

Evidence for Step Therapy in Diabetic Macular Edema

David C Musch et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

Comment on

  • Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.
    Jhaveri CD, Glassman AR, Ferris FL 3rd, Liu D, Maguire MG, Allen JB, Baker CW, Browning D, Cunningham MA, Friedman SM, Jampol LM, Marcus DM, Martin DF, Preston CM, Stockdale CR, Sun JK; DRCR Retina Network. Jhaveri CD, et al. N Engl J Med. 2022 Aug 25;387(8):692-703. doi: 10.1056/NEJMoa2204225. Epub 2022 Jul 14. N Engl J Med. 2022. PMID: 35833805 Free PMC article. Clinical Trial.

References

    1. Nayak RK, Pearson SD. The ethics of ‘fail first’: guidelines and practical scenarios for step therapy coverage policies. Health Aff (Millwood) 2014;33:1779–85. - PubMed
    1. Sachs RE, Kyle MA. Step therapy’s balancing act — protecting patients while addressing high drug prices. N Engl J Med 2022;386:901–4. - PMC - PubMed
    1. Jhaveri CD, Glassman AR, Ferris FL III, et al. Aflibercept monotherapy or bevacizumab first for diabetic macular edema. N Engl J Med 2022;387:692–703. - PMC - PubMed
    1. The Diabetic Retinopathy Clinical Research Network. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med 2015;372:1193–203. - PMC - PubMed
    1. Wells JA, Glassman AR, Ayala AR, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial. Ophthalmology 2016;123:1351–9. - PMC - PubMed